U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research (CDER)
  5. CDER Offices and Divisions
  6. CDER Division of Health Communication
  1. CDER Offices and Divisions

CDER Division of Health Communication

Who We Are

The Division of Health Communication (DHC) provides timely and accurate information to the public about approval and regulation of drugs, safety issues and the benefits and risks of drugs. The efforts of DHC help increase the understanding of CDER and its activities, foster informed decision-making and improve health.

What We Do

  • Provide strategic direction for CDER’s internal and external communication activities.
  • Communicate information to external health care journals and trade press.
  • Develop communication materials that promote the safe and effective use of medicines.
  • Conduct public outreach campaigns and education efforts.
  • Provide regulatory and science writing.
  • Provide editing assistance for annual reports and manuscripts submitted to scientific publications.
  • Manage CDER’s internal communication program and disseminating the center’s news to all staff members via a newsletter, multimedia projects and other activities.

Contact Us

Email: druginfo@fda.hhs.gov | Telephone: 301-796-3700 | Fax: 301-431-6352

Hillandale Building 10001 New Hampshire Avenue Silver Spring, MD 20993



Back to Top